spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yewdell, J. W.
Right arrow Articles by Bennink, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yewdell, J. W.
Right arrow Articles by Bennink, J. R.

Journal of Cell Science, Vol 114, Issue 5 845-851, Copyright © 2001 by Company of Biologists


JOURNAL ARTICLES

At the crossroads of cell biology and immunology: DRiPs and other sources of peptide ligands for MHC class I molecules

JW Yewdell, U Schubert and JR Bennink
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892-0440, USA.

CD8(+) T cells are a critical element of vertebrate immune responses to viruses and other intracellular parasites. They roam the body, monitoring cells for the presence of foreign peptides associated with MHC class I molecules of the major histocompatibility complex (MHC). Although it is clear that most of these peptides are generated through the action of proteasomes, the nature of the substrates degraded by proteasomes is an open question. Recent findings indicate that the major pool of substrates consists of a heterogeneous subset of proteins that are degraded within minutes of their synthesis. Evidence suggests that the fraction of newly synthesized proteins targeted for destruction is remarkably high - 30% or more, depending on cell type - possibly because they are defective in some way and cannot reach their intended conformation or location cellular in a time frame deemed appropriate by cells.


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Tellam, C. Smith, M. Rist, N. Webb, L. Cooper, T. Vuocolo, G. Connolly, D. C. Tscharke, M. P. Devoy, and R. Khanna
From the Cover: Regulation of protein translation through mRNA structure influences MHC class I loading and T cell recognition
PNAS, July 8, 2008; 105(27): 9319 - 9324.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
J. Tellam, M. H. Fogg, M. Rist, G. Connolly, D. Tscharke, N. Webb, L. Heslop, F. Wang, and R. Khanna
Influence of translation efficiency of homologous viral proteins on the endogenous presentation of CD8+ T cell epitopes
J. Exp. Med., March 19, 2007; 204(3): 525 - 532.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
A. O. Weinzierl, C. Lemmel, O. Schoor, M. Muller, T. Kruger, D. Wernet, J. Hennenlotter, A. Stenzl, K. Klingel, H.-G. Rammensee, et al.
Distorted Relation between mRNA Copy Number and Corresponding Major Histocompatibility Complex Ligand Density on the Cell Surface
Mol. Cell. Proteomics, January 1, 2007; 6(1): 102 - 113.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S.-B. Qian, E. Reits, J. Neefjes, J. M. Deslich, J. R. Bennink, and J. W. Yewdell
Tight Linkage between Translation and MHC Class I Peptide Ligand Generation Implies Specialized Antigen Processing for Defective Ribosomal Products
J. Immunol., July 1, 2006; 177(1): 227 - 233.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
E. Milner, E. Barnea, I. Beer, and A. Admon
The Turnover Kinetics of Major Histocompatibility Complex Peptides of Human Cancer Cells
Mol. Cell. Proteomics, February 1, 2006; 5(2): 357 - 365.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-B. Qian, M. F. Princiotta, J. R. Bennink, and J. W. Yewdell
Characterization of Rapidly Degraded Polypeptides in Mammalian Cells Reveals a Novel Layer of Nascent Protein Quality Control
J. Biol. Chem., January 6, 2006; 281(1): 392 - 400.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
E. Caron, R. Charbonneau, G. Huppe, S. Brochu, and C. Perreault
The structure and location of SIMP/STT3B account for its prominent imprint on the MHC I immunopeptidome
Int. Immunol., December 1, 2005; 17(12): 1583 - 1596.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
M. Ceppi, M. G. M. de Bruin, T. Seuberlich, C. Balmelli, S. Pascolo, N. Ruggli, D. Wienhold, J. D. Tratschin, K. C. McCullough, and A. Summerfield
Identification of classical swine fever virus protein E2 as a target for cytotoxic T cells by using mRNA-transfected antigen-presenting cells
J. Gen. Virol., September 1, 2005; 86(9): 2525 - 2534.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Herter, P. Osterloh, N. Hilf, G. Rechtsteiner, J. Hohfeld, H.-G. Rammensee, and H. Schild
Dendritic Cell Aggresome-Like-Induced Structure Formation and Delayed Antigen Presentation Coincide in Influenza Virus-Infected Dendritic Cells
J. Immunol., July 15, 2005; 175(2): 891 - 898.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
H. Lelouard, V. Ferrand, D. Marguet, J. Bania, V. Camosseto, A. David, E. Gatti, and P. Pierre
Dendritic cell aggresome-like induced structures are dedicated areas for ubiquitination and storage of newly synthesized defective proteins
J. Cell Biol., March 1, 2004; 164(5): 667 - 675.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
K. S. Voo, T. Fu, H. Y. Wang, J. Tellam, H. E. Heslop, M. K. Brenner, C. M. Rooney, and R.-F. Wang
Evidence for the Presentation of Major Histocompatibility Complex Class I-restricted Epstein-Barr Virus Nuclear Antigen 1 Peptides to CD8+ T Lymphocytes
J. Exp. Med., February 17, 2004; 199(4): 459 - 470.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
Y. Yin, B. Manoury, and R. Fahraeus
Self-Inhibition of Synthesis and Antigen Presentation by Epstein-Barr Virus-Encoded EBNA1
Science, September 5, 2003; 301(5638): 1371 - 1374.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
A. Admon, E. Barnea, and T. Ziv
Tumor Antigens and Proteomics from the Point of View of the Major Histocompatibility Complex Peptides
Mol. Cell. Proteomics, June 1, 2003; 2(6): 388 - 398.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. H. Glickman and A. Ciechanover
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
Physiol Rev, April 1, 2002; 82(2): 373 - 428.
[Abstract] [Full Text] [PDF]




© The Company of Biologists Ltd 2001